ARTICLE | Clinical News
Voclosporin: Additional Ph IIb AURA-LV data
March 10, 2017 8:09 PM UTC
Additional data from the double-blind, international Phase IIb AURA-LV trial in 265 patients with active lupus nephritis showed that twice-daily 23.7 and 39.5 mg oral voclosporin plus standard of care...
BCIQ Target Profiles